Alkermes
evolution to novel drug development with differentiated and contemporary approach employ integrated approach to target selection development and management with continuous evaluation of medical and economic value leverage advanced medicinal chemistry and protein engineering capabilities to develop novel molecular entities with strong intellectual property protection risk programs with front end loaded development plans utilizing forward and reverse translational medicine strategies | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
39 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Conference
January 2022
objective novel drug development with differentiated and disciplined approach | Alkermes
Related slides by other companies
AbCellera
Results
August 2021
forward integration accelerate drug development | AbCellera
AvePoint
Investor Day
March 2023
yare go to market approach go forward strategy | AvePoint
Blend
Investor Day
February 2024
blend priorities moving forward continue to deepen mortgage customer relationships through the economic cycle capture builder driven growth and financial benefits of platform strategy build on momentum towards free cash flow inflection | Blend
Certara
Investor Day
December 2021
virtual drug development for a neglected tropical disease | Certara
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io